{"lastClose": 1.1799999475479126, "len": 477, "date": "2023-02-08", "alpha_1": -0.91627104335339, "beta_1": 0.20449327153415311, "drawup_1": 0.7325581218050006, "natr_1": 30.907141946615468, "sup_1": -0.030790918986137682, "res_1": 0.285028279037709, "bullPattern_1": ["3OUTSIDE", "BELTHOLD"], "bearPattern_1": [], "rsi_1": 62.69756987716421, "adx_1": 26.80218257286061, "drawdown_1": -0.9065934078890032, "stratHoldSharpe_1": -1.847013989359631, "stratHoldAlpha_1": 249.72094693030184, "stratHoldDrawdown_1": -0.8170114523290357, "alpha_3mo": -0.7000894940373723, "beta_3mo": -0.40476284092332465, "drawup_3mo": 0.4117647223819081, "natr_3mo": 30.907141946615468, "sup_3mo": -0.05367233493393713, "res_3mo": 0.002824822513692253, "bullPattern_3mo": [], "bearPattern_3mo": [], "rsi_3mo": 75.97400980534705, "adx_3mo": 53.589690569435106, "drawdown_3mo": -0.4295301889923263, "stratHoldSharpe_3mo": 0.9289877890812025, "stratHoldAlpha_3mo": 251.64353137976133, "stratHoldDrawdown_3mo": -0.3980649523058215, "Country": "Cayman Islands", "Industry": "Biotechnology: In Vitro & In Vivo Diagnostic Substances", "Name": "LumiraDx Limited", "Sector": "Health Care", "Market Cap": 303239576, "alpha%_1": 0.004091066400738785, "beta%_1": 0.0637483771279912, "drawup%_1": 0.6869936874347871, "natr%_1": 1.0, "drawdown%_1": 0.004616779431299683, "stratHoldSharpe%_1": 0.0024516892809896607, "stratHoldAlpha%_1": 1.1341095029205732e-07, "stratHoldDrawdown%_1": 0.0056690884068905534, "alpha%_3mo": 0.07704862498973526, "beta%_3mo": 0.009806038662300905, "drawup%_3mo": 0.8167790187890169, "natr%_3mo": 1.0, "drawdown%_3mo": 0.0012071296296905295, "stratHoldSharpe%_3mo": 0.49240474422627506, "stratHoldAlpha%_3mo": 0.7687821772461247, "stratHoldDrawdown%_3mo": 0.0008626024894554682}